Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: Population based study

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  De Glas, Nienke A ^a   De Craen, Anton J M ^a   Bastiaannet, Esther ^a   Land, Ester G Op't ^a   Kiderlen, Mandy ^a   Van De Water, Willemien ^a   Siesling, Sabine ^b   Portielje, Johanneke E A ^c   Schuttevaer, Herman M ^d   De Bock, Geertruida Truuske H ^e   Van De Velde, Cornelis J H ^a   Liefers, Gerrit Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Cancer Registry and Research   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d RIJNLAND HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY CANCER; FEMALE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; NETHERLANDS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TREND STUDY; TUMOR INVASION; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DIAGNOSIS; INCIDENCE; PATHOLOGY; REGISTER; TRENDS;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; NEOPLASM STAGING; NETHERLANDS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 84913547175     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g5410     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011;61:409-18.
3. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst 2010;102:1468-77.
4. Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 2011;103:1101-11.
5. De Glas NA, Kiderlen M, Bastiaannet E, de Craen AJ, van de Water W, van de Velde CJ, et al. Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat 2013;138:561-9.
6. Van de Water W, Bastiaannet E, Hille ET, Meershoek-Klein Kranenbarg EM, Putter H, Seynaeve CM, et al. Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis. Oncologist 2012;17:55-63.
7. Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, et al. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 2005;92:151-6.
8. Van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D, et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012;307:590-7.
9. Paesmans M, Ameye L, Moreau M, Rozenberg S. Breast cancer screening in the older woman: an effective way to reduce mortality? Maturitas 2010;66:263-7.
10. Screening for breast cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-236.
11. NABON. Richtlijn Mammacarcinoom versie 2. 0. 2012. www. oncoline. nl/mammacarcinoom.
12. Fracheboud J, Groenewoud JH, Boer R, Draisma G, de Bruijn AE, Verbeek AL, et al. Seventy-five years is an appropriate upper age limit for population-based mammography screening. Int J Cancer 2006;118:2020-5.
13. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 2008;26:2482-8.
14. Galit W, Green MS, Lital KB. Routine screening mammography in women older than 74 years: a review of the available data. Maturitas 2007;57:109-19.
15. Esserman LJ, Shieh Y, Rutgers EJ, Knauer M, Retel VP, Mook S, et al. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 2011;130:725-34.
16. Cox B, Sneyd MJ. Bias in breast cancer research in the screening era. Breast 2013;22:1041-5.
17. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302:1685-92.
18. Statistics Netherlands. 2013. www. statline. nl.
19. Fracheboud J, Ineveld D, Bruijn M. National evaluation of breast cancer screening in the Netherlands. 1990-2007 (XII), 12th evaluation report. 2009, 1-106.
20. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998-2005.
21. Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res 2012;14:R10.
22. Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer. Cancer 2014;120:2649-56.
23. Autier P, Boniol M, Middleton R, Dore JF, Hery C, Zheng T, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 2011;22:1726-35.
24. Lousdal ML, Kristiansen IS, Moller B, Stovring H. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. Eur J Public Health 2014; published online 4 Mar.
25. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-7.
26. Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerink-Verheij JC, Otten JD, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73.
27. Broeders MJ, Verbeek AL, Straatman H, Peer PG, Jong PC, Beex LV, et al. Repeated mammographic screening reduces breast cancer mortality along the continuum of age. J Med Screen 2002;9:163-7.
28. Pelikan S, Moskowitz M. Effects of lead time, length bias, and false-negative assurance on screening for breast cancer. Cancer 1993;71:1998-2005.
29. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 2008;26:2482-8.
30. Aarts MJ, Voogd AC, Duijm LE, Coebergh JW, Louwman WJ. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands - associations with stage at diagnosis and survival. Breast Cancer Res Treat 2011;128:517-25.
31. Zackrisson S, Lindstrom M, Moghaddassi M, Andersson I, Janzon L. Social predictors of non-attendance in an urban mammographic screening programme: a multilevel analysis. Scand J Public Health 2007;35:548-54.
32. Autier P, Boniol M. Breast cancer screening: evidence of benefit depends on the method used. BMC Med 2012;10:163.
33. NHS Breast Screening Programme. Evaluating the age extension of the NHS Breast Screening Programme. 2012. www. cancerresearchuk. org/cancer-help/trials/a-study-toevaluate-an-age-extension-of-the-nhs-breast-screening-programme.
34. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001;285:2750-6.
35. Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA 2014;311:1336-47.